Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer

Molecular and Cellular Biochemistry

Volumn 268, Issue 1-2, 2005, Pages 19-24

  Michalaki, V ^a,b   Koutroulis, G ^a   Syrigos, K ^b   Piperi, C ^a   Kalofoutis, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

Breast cancer; Coronary artery disease; Endocrine therapy; Lipoproteins; Ultracentrifugation

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ATHEROSCLEROSIS; BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; DETERIORATION; EVALUATION; FEMALE; HORMONAL THERAPY; HUMAN; LABORATORY TEST; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PATHOGENESIS; PATIENT MONITORING; POSTMENOPAUSE; RISK FACTOR; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL2; LIPOPROTEINS, HDL3; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POSTMENOPAUSE; TRIGLYCERIDES;

EID: 14244263876     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-2993-4     Document Type: Article

References (31)

1. Feinleib M: A possible inverse relationship between serum cholesterol and cancer mortality. Am J Epidemiol 114: 5-10, 1981
2. Kritchevsky SB, Kritchevsky D: Serum cholesterol and cancer risk: An epidemiologic perspective. Ann Rev Nutr 12: 391-416, 1992
3. Kritz H, Zielinski C, Sinzinger H: Low cholesterol and cancer. J Clin Oncol 11: 3043-3048, 1996
4. Schreier LE, Berg GA, Basilio FM, Lopez GI, Etkin AE, Wikinski RL: Lipoprotein alterations, abdominal fat distribution and breast cancer. Biochem Mol Biol Int 4: 681-690, 1999
5. Clavel-Chapelon F, Niravong M, Joseph RR: Diet and breast cancer: Review of the epidemiologic literature. Cancer Detect Prev 21: 426-440, 1997
6. Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, Orentreich N: Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev 6: 483-488, 1998
7. Lane DM, Boatman KK, McConathy WJ: Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res Treat 34: 161-169, 1995. 10.1007/BF00665788
8. Mady EA: Association between estradiol, estrogen receptors, total lipids, triglycerides, and cholesterol in patients with benign and malignant breast tumours. Cancer Detect Prev 21: 426-440, 1997
9. Rossner S, Wallgren A: Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis 52: 246-339, 1984. 1:STN:280:BiqD2cnntFw%3D
10. Elisaf MS, Bairaktari ET, Nicolaides C, Kakaidi B, Tzallas CS, Katsaraki A, Pavlidis NA: Effect of letrozole on the lipid profile in postmenopausal women with breast cancer. Eur J Cancer 37: 1510-1513, 2001. 10.1016/S0959-8049(01)00155-1
11. Engan T, Krane J, Johannessen DC, Lonning PE, Kvinnsland S: Plasma changes in breast cancer patients during endocrine therapy - lipid measurements and nuclear magnetic resonance (NMR) spectroscopy. Breast Cancer Res Treat 36: 287-297, 1995. 10.1007/BF00713400
12. Assmann G, Schulte H: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 70: 733-737, 1992
13. Musliner TA, Krauss RM: Lipoprotein subspecies and risk of coronary disease. Clin Chem 34: 78-83, 1988
14. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62: 707-714, 1977. 10.1016/ 0002-9343(77)90874-9
15. Eisenberg S: High density lipoprotein metabolism. J Lipid Res 25: 1017-1058, 1984
16. De Lalla OF, Gofman JW: Ultracentrifugal analysis of serum lipoproteins. Methods Biochem Anal 1: 459-478, 1954
17. Eyre J, Hammett F, Miller NE: A micro-method for the rapid ultracentrifugal separation of human plasma high-density lipoprotein subfractions, HDL2 and HDL3. Clin Chim Acta 114: 225-231, 1998. 10.1016/ 0009-8981(81)90395-8
18. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475, 1974. 1:CAS:528:DyaE2cXkt1arsL8%3D
19. Fossati P, Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28: 2077-2080, 1982. 1:CAS:528:DyaL38XlvFGhtrk%3D
20. Goodwin PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A, Redwood S, Hood N, DelGiudice ME, Sidlofsky S, McCready D, Wilkinson R, Mahoney L, Connelly P, Page DL: Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 27: 284-292, 1997
21. Allampallam K, Dutt D, Nair C, Shetty V: The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes. J Hematother Stem Cell Res 9: 247-255, 2000. 10.1089/ 152581600319469
22. Mehta N, Hordines J, Volpe C, Doerr R, Cohen SA: Cellular effects of hypercholesterolemia in modulation of cancer growth and metastasis: A review of the evidence. Surg Oncol 3: 179-185, 1997. 10.1016/ S0960-7404(97)00027-3
23. Knapp ML, al-Sheibani S, Riches PG: Alterations of serum lipids in breast cancer: Effects of disease activity, treatment, and hormonal factors. Clin Chem 37: 2093-2101, 1991
24. Alexopoulos CG, Blatsios B, Avgerinos A: Serum lipids and lipoprotein disorders in cancer patients. Cancer 60: 3065-3070, 1987 1:STN:280:BieD2M3ltFY%3D
25. Borrelli R, del Sordo G, De Filippo E, Contaldo F, Parisi V, Beneduce G: High serum HDL-cholesterol in pre- and post-menopausal women with breast cancer in southern Italy. Adv Exp Med Biol 348: 149-153, 1993
26. Boyd NF, Connelly P, Lynch H, Knaus M, Michal S, Fili M, Martin LJ, Lockwood G, Tritchler D: Plasma lipids, lipoproteins, and familial breast cancer. Cancer Epidemiol Biomarkers Prev 4: 117-122, 1995
27. Fiorenza AM, Branchi A, Sommariva D: Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 30: 141-145, 2000. 10.1007/s005990070013
28. Vitols S, Gahrton G, Bjorkholm M, Peterson C: Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: Evidence from studies in patients with leukaemia. Lancet 8465: 1150-1154, 1985. 10.1016/S0140-6736(85)92679-0
29. Ray G, Husain SA: Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34: 71-76, 2001
30. Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA 288: 321-333, 2002
31. Goss PE: Risks versus benefits in the clinical application of aromatase inhibitors. Endocr.Relat Cancer 6: 325-332, 1999